MVX-505

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMVX-505
Drug Alias NamemAb for Pneumocystis pneumonia/pulmonary complications(MiniVax)mAb for Pneumocystis pneumonia(MiniVax)MVX-505
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung DiseasesPneumocystis Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMiniVax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMiniVax Inc
Active IndicationsN/A
Inactive IndicationsLung DiseasesPneumocystis Infections

Other Information

ATC CodeN/A
Related LinksN/A